Evaluation of Dry Fasting Effect during Ramadan on Protein Glycation in Saudi Individuals
International Journal of Biochemistry Research & Review, Volume 32, Issue 2,
Page 21-31
DOI:
10.9734/ijbcrr/2023/v32i2799
Abstract
Introduction: The non-enzymatic protein glycation alters protein function and contributes to many biochemical disorders. The accumulation of advanced glycation end-products (AGEs) is associated with the complications of diabetes, kidney disease, metabolic disorders and degenerative diseases.
Objectives: This study was designed to measure the level of some glycated proteins such as glycated insulin and glycated hemoglobin in Saudi volunteers before and after dry fasting in Ramadan.
Methods: Blood samples were collected twice; first sample (before) and second sample (after) dry fasting. The study included 45 Saudi male volunteers, whose ages ranged between23 and 52 years They were divided into four groups: healthy, type II diabetic patients, smokers, and obese individuals. Plasma glucose level and HbA1c were measured immediately using (Beckman coulter). Assessment of insulin resistance was determined using the equation of homeostasis model for insulin resistance (HOMA-IR). Plasma insulin level and glycated insulin % were assayed by TSQ Vantage Triple Stage Quadruple LC/MS Mass Spectrometer from Thermo Scientific.
Results: Level of HbA1c, HOMA IR and glycated insulin in healthy, type II diabetic patients, smokers, and obese individuals showed significant decrease in the second sample. The level of HbA1c showed a significant decrease (p-value <0.0001) after dry fasting (5.69 ± 1.55 %), (6.14 ± 1.77%). The level of HOMA IR showed significant decrease (p-value <0.0001) after dry fasting (1.97 ± 1), (2.46 ± 1.28). The level of glycated insulin showed significant decrease (p-value <0.0001) after dry fasting (6.25 ± 2%), (7.71 ± 2.48%).
Conclusion: Glucose, HbA1c, HOMA IR, and glycated insulin levels showed a significant decrease after dry fasting. Reduced protein glycation and formation of advanced glycation end products, can improve the clinical course of many medical disorders. More researches are needed to understand the molecular mechanisms behind glycation-induced clinical disorders and diseases, as well as to correlate these mechanisms to the diagnosis and prevention of lifestyle-related diseases.
- Protein glycation
- glycated insulin
- maillard reaction
- dry fasting
- insulin resistance
How to Cite
References
Maillard L. Action des acides amines sur les sucres: formation des melanoidines par voie methodologique. C R Acad Sci. 1912;156:148-9.
Hodge JE. The Amadori rearrangement. Adv Carbohydr Chem. 1955;10:169-205.
Wells-Knecht KJ, Brinkmann E, Wells-Knecht MC, Litchfield JE, Ahmed MU, Reddy S et al. New biomarkers of Maillard reaction damage to proteins. Nephrol Dial Transplant. 1996;11;Suppl 5:41-7.
Koenig RJ, Peterson CM, Kilo C, Cerami A, Williamson JR. Hemoglobin AIc as an indicator of the degree of glucose intolerance in diabetes. Diabetes. 1976; 25(3):230-2.
Rowan S, Bejarano E, Taylor A. Mechanistic targeting of advanced glycation end-products in age-related diseases. Biochim Biophys Acta Mol Basis Dis. 2018;1864(12):3631-43.
Cheng RZ, Kawakishi S. Site-specific oxidation of histidine residues in glycated insulin mediated by Cu2+. Eur J Biochem. 1994;223(3):759-64.
Nowotny K, Schröter D, Schreiner M, Grune T. Dietary advanced glycation end products and their relevance for human health. Ageing Res Rev. 2018;47:55-66.
Welton S, Minty R, O’Driscoll T, Willms H, Poirier D, Madden S et al. Intermittent fasting and weight loss: systematic review. Can Fam Phys. 2020;66(2):117-25.
Grajower MM, Horne BD. Clinical management of intermittent fasting in patients with diabetes mellitus. Nutrients. 2019;11(4):873.
Haluzík M, Mráz M. Intermittent fasting and prevention of diabetic retinopathy: where do we go from Here? Diabetes. 2018; 67(9):1745-7.
Bashir MI, Pathan MF, Raza SA, Ahmad J, Khan AK, Ishtiaq O et al. Role of oral hypoglycemic agents in the management of type 2 diabetes mellitus during Ramadan. Indian J Endocrinol Metab. 2012;16(4):503-7.
Norouzy A, Mohajeri SM, Shakeri S, Yari F, Sabery M, Philippou E et al. Effect of Ramadan fasting on glycemic control in patients with type 2 diabetes. J Endocrinol Invest. 2012;35(8):766-71.
Khatib FA, Shafagoj YA. Metabolic alterations as a result of Ramadan fasting in non-insulin-dependent diabetes-mellitus patients in relation to food intake. Saudi Med J. 2004;25(12):1858-63.
Almaatouq MA. Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan. Diabetes Metab Syndr Obes. 2012;5: 109-19.
Bonakdaran SH, Khajeh-Dalouie M. The effects of fasting during Ramadan on glycemic excursions detected by continuous glucose monitoring system (CGMS) in patients with type 2 diabetes. Med J Malaysia. 2011;66(5):447-50.
Zouhal H, Saeidi A, Salhi A, Li H, Essop MF, Laher I, et al. Exercise training and fasting: current insights. Open Access J Sports Med. 2020;11:1-28.
Bachman JL, Deitrick RW, Hillman AR. Exercising in the fasted state reduced 24-hour energy intake in active male adults. J Nutr Metab. 2016;2016:1984198.
Almeneessier AS, BaHammam AS. How does diurnal intermittent fasting impact sleep, daytime sleepiness, and markers of the biological clock? Current insights. Nat Sci Sleep. 2018;10:439-52.
AlAlwan I, Al Banyan A. effects of Ramadan fasting on children with type 1 diabetes. IJDM. 2010;2:127-9.
Bouguerra R, et al. ’Metabolic effects of Ramadan fasting on type 2 diabetes.’ EMHJ-eastern Mediterranean Health Journal. 2003;9(5-6):1099-108.
Khaled BM, Belbraouet S. Effect of Ramadan fasting on anthropometric parameters and food consumption in 276 type 2 diabetic obese women. Int J Diabetes Dev Ctries. 2009;29(2): 62-8.
Sulimani R. lLaajam O, Ala-Alas O, Famuyiwa FO, Bashi S, Mekki M. The effect of Ramadan fasting on diabetes control in type II Diabetic Patients Nutr Res. 1991;11:261-64.
Uysal AR, Erdoğan MF, Sahin G, Kamel N, Erdoğan G. Clinical and metabolic effects of fasting in 41 type 2 diabetic patients during Ramadan. Diabetes Care. 1998; 21(11):2033-4.
Salti I, Bénard E, Detournay B, Bianchi-Biscay M, Le Brigand C, Voinet C, et al. A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes Care. 2004;27(10):2306-11.
Shadman Z, Poorsoltan N, Akhoundan M, Larijani B, Soleymanzadeh M, Akhgar Zhand C et al. Ramadan major dietary patterns. Iran Red Crescent Med J. 2014; Sep;16(9):e16801.
Shadman Z, Akhoundan M, Nikoo MK. A review of Ramadan fasting and diabetes mellitus: controversies regarding the effects of Ramadan Fasting on Diabetic Patients. 2014;2(3):119-30.
Saleh SA, El-Kemery TA, Farrag KA, Badawy MR, Sarkis NN, Soliman FS, et al. Ramadan fasting: relation to atherogenic risk among obese Muslims. J Egypt Public Health Assoc. 2004;79(5-6):461-83.
Khaled BM, Bendahmane M, Belbraouet S. Ramadan fasting induces modifications of certain serum components in obese women with type 2 diabetes. Saudi Med J. 2006;27(1):23-6.
Khaled BM, Belbraouet S. Effect of Ramadan fasting on anthropometric parameters and food consumption in 276 type 2 diabetic obese women. Int J Diabetes Dev Ctries. 2009;29(2):62-8.
Margină D, Ungurianu A, Purdel C, Nițulescu GM, Tsoukalas D, Sarandi E et al. Analysis of the intricate effects of polyunsaturated fatty acids and polyphenols on inflammatory pathways in health and disease. Food Chem Toxicol. 2020; Sep 1;143:111558.
Margină D, Ungurianu A, Purdel C, Tsoukalas D, Sarandi E, Thanasoula M et al. Chronic inflammation in the context of everyday life: dietary changes as mitigating factors. Int J Environ Res Public Health. 2020;17(11):4135.
Nowosad K, Sujka M. Effect of various types of intermittent fasting (IF) on weight loss and improvement of diabetic parameters in human. Curr Nutr Rep. 2021; 10(2):146-54.
Ganesan K, Habboush Y, Dagogo-Jack S. Calorie restriction and intermittent fasting: impact on glycemic control in people with diabetes. Diabetes Spectr. 2020;33(2): 143-8.
Soeters MR, Lammers NM, Dubbelhuis PF, Ackermans M, Jonkers-Schuitema CF, Fliers E et al. Intermittent fasting does not affect whole-body glucose, lipid, or protein metabolism. Am J Clin Nutr. 2009;90(5): 1244-51.
Guilbaud A, Niquet-Leridon C, Boulanger E, Tessier FJ. How can diet affect the accumulation of advanced glycation end-products in the human body? Foods. 2016;5(4):84.
Prasetya G, Sapwarobol S. Intermittent fasting during Ramadan improves insulin sensitivity and anthropometric parameters in healthy young Muslim men. Am J Lifestyle Med. 2021;15(2):200-6.
Petersen MC, Shulman GI. Mechanisms of insulin action and insulin resistance. Physiol Rev. 2018;98(4):2133-223.
Sutton EF, Beyl R, Early KS, Cefalu WT, Ravussin E, Peterson CM, [et al. write the reference fully] Early Time-Restricted Feeding Improves Insulin Sensitivity. Early Time-Restricted Feeding Improves Insulin Sensitivity, Blood pressure, and oxidative stress even without weight loss in men with prediabetes. Cell Metab. 2018;27(6):1212-1221.e3.
-
Abstract View: 47 times
PDF Download: 43 times
